Public Release: 

Structure of cog at the hub of metabolism reveals anti-ageing function

Imperial College London

The structure of a key energy-releasing enzyme found in all animals is designed to minimise free radical production, an international team of researchers report in the journal Science today.

In a startling feat of structural biology, the team visualised the entire molecular structure of succinate dehydrogenase in the bacterium E. coli, allowing them to see for the first time how the protein's three-dimensional shape helps prevent the formation of large quantities of these destructive oxygen atoms.

Formed as a by-product during cellular respiration, free radical can cause havoc in cells by reacting with DNA or the cell membrane, knocking out or impairing their function, a process linked to cellular ageing.

Professor Paul Fremont, Director of Imperial's Centre for Structural Biology, said: "Professor Iwata's group have performed an extraordinary feat in obtaining the first three-dimensional insights of succinate dehydrogenase.

"This fundamentally important and highly complex metabolic enzyme protects the bacterium from self inflicted damage and lies at the heart of the cell's energy powerhouse. It acts like a built in anti-pollution system, and has significant implications for understanding human ageing."

Professor So Iwata of Imperial College London, senior author of the paper added: "Solving the structure of succinate dehydrogenase opens up new leads in the quest to understand longevity and ageing.

"It now appears that a wide variety of genetic disorders including muscle and neurodegenerative diseases, and tumour formation, are caused by defective forms of this enzyme - as a result of increased free radical formation."

"The challenge now is to try and engineer succinate dehydrogenase to maximise its efficiency. The E. coli bacterium provides a flexible model to advance this research because the enzyme is very similar to the human version."

Cellular respiration is the process of oxidizing food molecules, like glucose, to release energy for use in the body. Found deep inside most human cells in tiny power plants called mitochondria, succinate dehydrogenase plays a key part in this process when oxygen is present. Embedded in the inner membrane of the mitochondria, the enzyme is involved in a system that transfers energy using electrons.

Using the latest X-ray crystallography techniques, Imperial PhD student, Rob Horsfield solved the structure of succinate dehydrogenase. Researchers from the UK, Sweden, the United States and Japan were then able to probe the three-dimensional structure of the protein, to examine how the enzyme releases energy by breaking down a derivative of glucose, succinate, to a smaller molecule fumarate.

To determine what factors influence free radical production, the team compared the structure of succinate dehydrogenase to a similar enzyme, fumarate reductase.

"Until now, it has been unclear why cells preferentially use succinate dehydrogenase in the presence of oxygen and fumarate reductase in its absence to perform the same job," explains Professor Iwata.

"Previous research indicates that fumarate reductase produces 120 times more superoxide than succinate dehydrogenase in the presence of oxygen. Now, we can see why subtle differences between the two structures means that when energy is released from succinate it is not transferred to the next stage of respiration but leaks out, leading to superoxide production."

Professor Iwata added: "Succinate dehydrogenase's structure is far more efficient at handing that energy onto the next stage of respiration. It seems likely that there has been evolutionary pressure for organisms to pick succinate dehydrogenase to limit the damage inflicted on cells by superoxide production."


Notes to editors

Journal: Science (31 January 2003)

Title: Molecular architecture of succinate dehydrogenase (complex II) prevents reactive oxygen species generation

Authors: Victoria Yankovskaya (1), Rob Horsefield (2), Susanna Tornroth (3), Cesar Luna-Chavez (1,4), Hideto Miyoshi (5), Christophe Leger (6), Bernadette Byrne (2), Gary Cecchini (1,4) and So Iwata (2,3,7)

(1) Molecular Biology Division, VA Medical Center, San Francisco, CA 94121 USA
(2) Department of Biological Sciences, Imperial College London, SW7 2AY, UK
(3) Uppsala University, Department of Biochemistry, BMC Box 576, S-75123 Uppsala, Sweden
(4) Department of Biochemistry and Biophysics, University of California San Francisco, CA 94143, USA
(5) Division of Applied Life Sciences Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan
(6) Inorganic Chemistry Laboratory, Oxford University, South Parks Road, Oxford, OX1 3QR, UK
(7) Division of Biomedical Sciences, Imperial College London, SW7 2AZ, UK

About Imperial College London

Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (10,000) and staff (5000) of the highest international quality.

Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions, which enhance the quality of life and the environment - underpinned by a dynamic enterprise culture. Website:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.